Core Alternative Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Core Alternative Capital's BSX Position: Q2 2026 in Review
Core Alternative Capital increased its Boston Scientific (BSX) stake by 20% in Q2 2026, buying an estimated $20.5K and bringing the position to 2,262 shares worth $96.5K. The position accounts for 0.03% of the portfolio, ranked #131.
Core Alternative Capital first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $148K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Core Alternative Capital held 2,262 shares of Boston Scientific worth $96.5K as of Q2 2026.
- Core Alternative Capital bought 377 Boston Scientific shares in Q2 2026, an estimated $20.5K.
- Boston Scientific made up 0.03% of Core Alternative Capital's portfolio in Q2 2026, its #131 holding.
- Core Alternative Capital first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
- Core Alternative Capital's Boston Scientific position peaked at $148K in Q4 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.